COLESTID

This brand name is authorized in Canada, Estonia, Spain, Israel, New Zealand, United Kingdom, United States

Active ingredients

The drug COLESTID contains one active pharmaceutical ingredient (API):

1 Colestipol UNII X7D10K905G - COLESTIPOL HYDROCHLORIDE

Colestipol is an ion exchange resin which lowers plasma cholesterol through binding with bile acids in the intestinal lumen. It is indicated as adjunctive therapy to diet in the management of patients with elevated cholesterol levels who have not responded adequately to diet. Read about Colestipol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
COLESTID Tablet	FDA, National Drug Code (US)	MPI, US: SPL/Old
COLESTID Granule for oral suspension	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC
COLESTID Granule for oral suspension	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C10AC02	Colestipol	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AC Bile acid sequestrants
Discover more medicines within C10AC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 00642975, 02132680
Country: EE	Ravimiamet	Identifier(s): 1827042
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 55596
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 40831, 40838
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 29
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 2289
Country: US	FDA, National Drug Code	Identifier(s): 0009-0260, 0009-0370, 0009-0450